Meta-Analysis of the Efficacy and Safety of Interleukin-23-Targeted Drugs in the Treatment of Moderate-to-Severe Psoriasis

In this study, our purpose was to systematically evaluate the efficacy and safety of interleukin-23 (IL-23)-targeted drugs in the treatment of moderate-to-severe psoriasis and provide an evidence-based reference for clinical treatment. A computer search of PubMed, EMBASE, Web of Science, Cochrane Li...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Teng, Ma, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256449/
https://www.ncbi.nlm.nih.gov/pubmed/35845729
http://dx.doi.org/10.1155/2022/2172980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256449/
https://www.ncbi.nlm.nih.gov/pubmed/35845729
http://dx.doi.org/10.1155/2022/2172980

Ejemplares similares